GlassScriptPhysician profile
Daniel S Hakeem
NPI 1346609179
$1,327.93
in general payments reported to CMS, 2019-2025
22 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $167 · 2022: $206 · 2023: $319 · 2024: $251 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $156.61 | 2023-2025 | Axios, Spyscope Ds |
| Abbvie INC. | $124.74 | 2021 | |
| Smith+Nephew, INC. | $106.78 | 2023-2025 | Pico 7, Renasys Go V2 Home, Allevyn Life L 15.4x15.4 Ctn10 |
| Davol INC. | $100.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.90 | 2021-2024 | Gattex |
| W. L. Gore & Associates, INC. | $95.25 | 2024 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Novo Nordisk INC | $81.16 | 2025 | Wegovy |
| Tela Bio, INC. | $71.68 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $66.89 | 2024 | |
| Angiodynamics, INC. | $57.27 | 2021-2022 | |
| Lilly USA, LLC | $53.47 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $47.33 | 2022-2025 | Keytruda, Lynparza |
| Integra Lifesciences Corporation | $46.33 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Enterra Medical, INC. | $40.78 | 2023 | |
| Becton, Dickinson and Company | $39.09 | 2024 | Phasix Mesh |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $36.22 | 2023 | Seglentis |
| Medtronic, INC. | $20.96 | 2024 | Ligasure |
| Tactile Systems Technology INC | $18.79 | 2025 | Nimbl, Flexitouch Plus |
| Eagle Pharmaceuticals, INC. | $17.79 | 2023 | |
| Olympus America INC. | $16.09 | 2025 | Gastrointestinal Videoscope, Olympus |
| Merit Medical Systems INC | $15.64 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hakeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.